Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.

Journal of molecular and cellular cardiology - 1 Dec 2013

Kuster Diederik W D, Mulders Joyce, Ten Cate Folkert J, Michels Michelle, Dos Remedios Cristobal G, da Costa Martins Paula A, van der Velden Jolanda, Oudejans Cees B M

Abstract excerpt

Hypertrophic cardiomyopathy (HCM) is predominantly caused by mutations in genes encoding sarcomeric proteins. One of the most frequent affected genes is MYBPC3, which encodes the thick filament protein cardiac myosin binding protein C. Despite the prevalence of HCM, disease pathology and clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy, Hypertrophic
Share to Computer Simulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to MicroRNAs

Share to Myocardium

Share to Transcriptome

Share to Troponin I

Share to TRPM Cation Channels

Source

Identifiers

PMID: 24083979
DOI: 10.1016/j.yjmcc.2013.09.012

Genes

MYBPC3
TRPM3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-24083979-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.PMID 24083979Read ↗

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations.Semantic proximity Read ↗

Hypertrophic cardiomyopathy in MYBPC3 carriers in agingSemantic proximity Read ↗

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Targeting the population for gene therapy with MYBPC3.Semantic proximity Read ↗

Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology.Semantic proximity Read ↗

The impact of non-cardiomyocyte <i>MYBPC3</i> expression on the development of hypertrophic cardiomyopathySemantic proximity Read ↗

MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correctionSemantic proximity Read ↗

Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive ReviewSemantic proximity Read ↗

Myosins and MyomiR Network in Patients with Obstructive Hypertrophic CardiomyopathySemantic proximity Read ↗

Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.Semantic proximity Read ↗

A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic CardiomyopathySemantic proximity Read ↗

Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.